Agilent Joins AMBIC to Advance Biomanufacturing
SANTA CLARA, Calif., April 04, 2022 – Agilent Technologies Inc.
(NYSE: A) announced today that it has become a member of the Advanced
Mammalian Biomanufacturing Innovation Center (AMBIC). Joining AMBIC
demonstrates the company’s commitment to partnering to support the
provision of the next generation of analytical tools and comprehensive
solutions needed by academic, pharmaceutical, and clinical researchers.
More info >> |